GCT passed Sponsor Audit with no findings

GCT has recently passed a sponsor audit in St. Petersburg, Russia. The sponsor company is one of the leading vaccine developers with a rapid clinical pipeline. The remote audit was conducted in order to confirm GCT’s adherence to GCP, the Declaration of Helsinki, the Rules of proper clinical practice of the Eurasian Economic Union, the local Russian regulations, and the sponsor’s policies. No major findings were identified. Following the audit, GCT was approved as a vendor of category “A” and authorized to participate in the sponsor’s commercial tenders.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.